foxo4-dri senolytic animal model 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Heterogeneity of Cellular Senescence, Senotyping,
Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Targeting the FOXO4 p53 axis by retro inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



